All Companies
LLY
Eli Lilly & Co.Pharmaceutical Preparations
$1,152.93updated Sep 19, 2026
Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Angus S. King Jr.I | Jan 26, 2026 | Dec 29, 2025 | Buy | $1,001 - $15,000 | +6.88% |
| Markwayne MullinR | Jan 16, 2026 | Dec 29, 2025 | Buy | $15,001 - $50,000 | +6.88% |
| Shelley Moore CapitoR | Nov 4, 2025 | Oct 24, 2025 | Buy | $1,001 - $15,000 | +39.67% |
| John BoozmanR | Sep 12, 2025 | Aug 22, 2025 | Buy | $1,001 - $15,000 | +62.00% |
| John BoozmanR | Sep 12, 2025 | Aug 11, 2025 | Buy | $1,001 - $15,000 | +81.50% |
| Ashley MoodyR | Mar 22, 2025 | Mar 6, 2025 | Buy | $100,001 - $250,000 | +26.31% |
| Ron WydenD | Feb 21, 2025 | Jan 22, 2025 | Buy | $50,001 - $100,000 | +52.91% |